JORDAN JULIE (Chief Medical Officer) sold 6.2% of their position (828.00 shares) of NEUROGENE INC. on the open market
Open‑market sale worth $18.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/30/2026ACC: 0001968554-26-000005
Officer· Chief Medical Officer
Since Feb 2026
-828.00
Net shares
Net seller
$18.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
828.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−828.00
Price / share
$21.89
Trade value
$18.13K
% of position
6.2%
3/26/2026
13.30K→12.47K
Total
Net shares
−828.00
Net value
-$18.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/26/2026 | S · Sale | −828.00 | $21.89 | $18.13K | 6.2% | 13.30K | 12.47K |
| Total | −828.00 | -$18.13K | ||||||
Derivative Transactions0
No derivative transactions reported